These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 41024)
1. The medical management of the patient with recurrent affective disorder. Christie WR; Samuelsen TW J Maine Med Assoc; 1979 Oct; 70(10):387-8, 391-4. PubMed ID: 41024 [No Abstract] [Full Text] [Related]
2. How long should prophylactics be continued in affective disorders? Freyhan FA Pharmakopsychiatr Neuropsychopharmakol; 1976 May; 9(3):137-41. PubMed ID: 981328 [TBL] [Abstract][Full Text] [Related]
3. Long-term maintenance drug therapy in recurrent affective illness: current status and issues. Prien RF; Caffey EM Dis Nerv Syst; 1977 Dec; 38(12):981-92. PubMed ID: 412649 [No Abstract] [Full Text] [Related]
4. Neuropsychopharmacology and the affective disorders. (First of three parts). Schildkraut JJ N Engl J Med; 1969 Jul; 281(4):197-201 contd. PubMed ID: 4892804 [No Abstract] [Full Text] [Related]
5. [Psychotropic drugs (effects and indications)]. Calanca A Rev Med Suisse Romande; 1974 Jul; 94(7):575-86. PubMed ID: 4842890 [No Abstract] [Full Text] [Related]
6. [Clinico-catamnestic study of the development of remissions in adolescents suffering recurrent schizophrenia]. Simashkova NV Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(10):1536-40. PubMed ID: 2866647 [TBL] [Abstract][Full Text] [Related]
7. Lithium in affective disorders. Scardino J N Y State J Med; 1970 Mar; 70(5):638-42. PubMed ID: 4907068 [No Abstract] [Full Text] [Related]
8. [Lithium in the prophylaxis of recurrent affective disorders. Effectiveness of low plasma levels and predictors to clinical response (author's transl)]. Faravelli C; Marchetti G; Benvenuti P; Cabras PL Riv Patol Nerv Ment; 1980; 101(6):261-71. PubMed ID: 6801749 [TBL] [Abstract][Full Text] [Related]
9. Nutritional management of patients undergoing long-term antipsychotic and antidepressant therapies. Jackson RT; Haynes-Johnson V Arch Psychiatr Nurs; 1988 Jun; 2(3):146-52. PubMed ID: 2899420 [No Abstract] [Full Text] [Related]
11. An overview of the treatment of schizoaffective disorder. McElroy SL; Keck PE; Strakowski SM J Clin Psychiatry; 1999; 60 Suppl 5():16-21; discussion 22. PubMed ID: 10192403 [TBL] [Abstract][Full Text] [Related]
12. Drug therapoy of clinical depressions--current status and implications for research on neuropharmacology of the affective disorders. Klerman GL J Psychiatr Res; 1972 Sep; 9(3):253-70. PubMed ID: 4404777 [No Abstract] [Full Text] [Related]
13. [The management of the pregnant patient with psychiatric problems]. González Manrique M Bol Asoc Med P R; 1990 Jun; 82(6):255-8. PubMed ID: 1977401 [No Abstract] [Full Text] [Related]
14. [Lithium maintenance therapy in affective and in schizoaffective psychosis (author's transl)]. Tress W; Haag H Nervenarzt; 1979 Aug; 50(8):524-6. PubMed ID: 119166 [No Abstract] [Full Text] [Related]
15. Consensus guidelines outline drug selection and sequencing options for bipolar disorder. Rep Med Guidel Outcomes Res; 2000 May; 11(10):1-2, 5. PubMed ID: 11770548 [No Abstract] [Full Text] [Related]
16. [The changing drug therapy of bipolar disorder]. Leinonen E Duodecim; 1999; 115(17):1911-7. PubMed ID: 11941660 [No Abstract] [Full Text] [Related]
17. Neurochemical studies of the affective disorders: the pharmacological bridge. Schildkraut JJ Am J Psychiatry; 1970 Sep; 127(3):358-60. PubMed ID: 5460154 [No Abstract] [Full Text] [Related]
18. Neuropharmacological studies of mood disorders. Schildkraut JJ Proc Annu Meet Am Psychopathol Assoc; 1972; 60():65-92. PubMed ID: 4551137 [No Abstract] [Full Text] [Related]